- In January 2018, Nevro Corp stated that its spinal cord stimulation device, the Senza II Spinal Cord Stimulation (SCS) System, which delivers HF10 therapy, had been approved by the U.S Food and Drug Administration.
- In January 2017, Abbott announced the purchase of St. Jude Medical Inc., which included the company's complete product portfolio as well as its pharmaceuticals sector. A global leader in medical equipment is projected to emerge with this transaction.
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Rechargeable Spinal Cord Stimulator Systems, Non-Rechargeable Spinal Cord Stimulator Systems), Application (Sciatica, FBS, Arachnoiditis, Degenerative Disk Disease, Others) – Industry Trends and Forecast to 2031.
.
The Global Spinal Cord Stimulators Market size was valued at USD 2.45 USD Billion in 2023.
The Global Spinal Cord Stimulators Market is projected to grow at a CAGR of 8.1% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
